Aegis is Awarded US Patent for Formulation and Non-invasive Delivery of Peptide Drugs
15 août 2018 06h00 HE
|
Aegis Therapeutics LLC
SAN DIEGO, Aug. 15, 2018 (GLOBE NEWSWIRE) -- Aegis Therapeutics LLC announced today that it has been awarded US Patent No. 10,046,025, providing non-invasive delivery of cyclic peptide drugs....
Aegis Expands its International and US Intravail® Patent Portfolio on Multiple Fronts
02 août 2018 06h00 HE
|
Aegis Therapeutics LLC
SAN DIEGO, Aug. 02, 2018 (GLOBE NEWSWIRE) -- Aegis Therapeutics LLC announced today that it has been awarded European Patent No. EP2381773(B1) and Canadian Patent No. 2,748,268, providing fast...